gyki 52466 has been researched along with Cardiac Death in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wienrich, M | 1 |
| Brenner, M | 1 |
| Löscher, W | 1 |
| Palluk, R | 1 |
| Pieper, M | 1 |
| Potschka, H | 1 |
| Weiser, T | 1 |
1 other study available for gyki 52466 and Cardiac Death
| Article | Year |
|---|---|
In vivo pharmacology of BIIR 561 CL, a novel combined antagonist of AMPA receptors and voltage-dependent Na(+) channels.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Anticonvulsa | 2001 |